BioSpace News Archive

BioCurate , an independently operated joint venture between the University of Melbourne and Monash University, and with support of the Victorian State Government, today announced the appointment of Dr Damien Bates as Acting CEO, with Founding CEO Dr C. Glenn Begley transitioning to a specialist scientific, commercial and strategic advisory role

Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, (“Baudax Bio” or the “Company”) today announced that it has entered into a definitive agreement with institutional and accredited investors for the purchase and sale of an aggregate of 11,000,000 shares of common stock at a purchase price of $1.60 per share in a registered direct offering priced at-the-market under Nasdaq rules. The closing o

Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT) today announced the dosing of the first patient in a confirmatory pharmacokinetic (“PK”) study for OPNT003, nasal nalmefene, for the treatment of opioid overdose. Results from the study are anticipated June 2021.

Mati Therapeutics Inc. (“Mati”) announced that a peer reviewed manuscript of a Phase II clinical trial evaluating the safety and efficacy of Nepafenac delivered via Mati’s proprietary Evolute® sustained ocular drug delivery platform has been published in the February Journal of Cataract and Refractive Surgery.

Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, announced today it has filed a “universal shelf” registration statement on Form S-3 with the Securities and Exchange Commission (SEC).

Mitsubishi Tanabe Pharma America, Inc. celebrated its five-year anniversary of being established in the United States in 2016.

Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today filing of a new patent application with data demonstrating that mice immunized with StemVacs possesses a type of “memory” natural killer cells which are capable of transferring immunity to naïve mice.

Previon™, the leader in providing at-home patient testing kits, healthcare screening and patient engagement communications, announced it has partnered with Spectrum Solutions™, manufacturer of the first FDA EUA-authorized saliva collection kit for COVID-19 testing

Apollo Endosurgery, Inc. (“Apollo”) (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric procedures, announced today a planned CEO change. Effective March 1, 2021, Charles (Chas) McKhann will become CEO and a member of the Board of Directors.

Prevalence of hospital-acquired infections (HAI) in the developing countries across the world will anchor the adoption of sterilization medical equipment through the next few years.